Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2008
12/09/2008CA2217855C Tetralines
12/04/2008WO2008147956A2 Toll-like receptor 3 modulators and uses thereof
12/04/2008WO2008147417A1 Method of treating diabetes
12/04/2008WO2008147283A1 The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
12/04/2008WO2008147245A2 Controlled release proxodolol pharmaceutical composition
12/04/2008WO2008146914A1 Heterocyclic compound
12/04/2008WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
12/04/2008WO2008146753A1 Therapeutic agent for cerebral infarction
12/04/2008WO2008146721A1 Prophylactic or therapeutic agent for age-related macular degeneration
12/04/2008WO2008146063A1 New benzofuran derivatives as selective 5ht6 receptor inhibitors and process for their preparation
12/04/2008WO2008145375A2 Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development
12/04/2008WO2008145135A1 Antidepressiva for treatment of metabolic syndrome
12/04/2008WO2008145064A1 The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof
12/04/2008WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
12/04/2008WO2008125800A3 Mmp activated vascular disrupting agents
12/04/2008WO2008104512A3 Novel polymorphs of aprepitant and processes for preparation
12/04/2008WO2008099144A3 Tgf-beta stimulant and further agent to reduce side effects
12/04/2008WO2008067863A3 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
12/04/2008WO2008062905A3 Heteromonocyclic compound and use thereof
12/04/2008WO2008036387A3 Method of treating endothelial dysfunction
12/04/2008WO2008022974A3 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof
12/04/2008US20080300316 Substituted phenethylamines
12/04/2008US20080300286 Tyrosine Derivatives Substituted By N-Arylacryloyl as Agonists of Hppar Alpha and/or Hppar Gamma
12/04/2008US20080300278 central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents; cardiovascular disorders
12/04/2008US20080300268 Heterocyclic compounds and uses thereof
12/04/2008US20080300253 Treatment of inflammatory disorders with praziquantel
12/04/2008US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
12/04/2008US20080300236 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/04/2008US20080300235 FXR Agonists for Reducing LOX-1 Expression
12/04/2008US20080300233 Pharmaceutical Composition Comprising Simvastatin and Ezetimibe
12/04/2008US20080300228 Crystalline Rostafuroxin
12/04/2008US20080300227 Drugs for treating hypertension combined with hyperuricemia and/or hypercholesterolemia
12/04/2008US20080300220 Linkable Lewis X Analogs
12/04/2008US20080300196 Monosaccharide derivatives
12/04/2008US20080300181 Methods of using IL-1 antagonists to treat neointimal hyperplasia
12/04/2008US20080299238 Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease
12/04/2008US20080299195 Use of ranolazine for elevated brain-type natriuretic peptide
12/04/2008US20080299187 Substances for Reducing Occurence of Major Cardiac Events in Humans
12/04/2008US20080299174 Bis-(Alpha-Amino)-Diol-Diester-Containing Poly (Ester Amide) and Poly (Ester Urethane) Compositions and Methods of Use
12/04/2008US20080299164 Substituted polycaprolactone for coating
12/04/2008US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof
12/04/2008US20080299134 Recombinant Anti-Interleukin-9 Antibodies
12/04/2008US20080299129 Antagonists to il-17a, il-17f, and il-23p19 and methods of use
12/04/2008US20080299119 Polypeptides homologous to vegf and bmp1
12/04/2008US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof
12/04/2008US20080299090 Use Of Umbilical Cord Matrix Cells
12/04/2008US20080299089 Endogeneous repair factor production promoters
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008CA2689957A1 Metabolic imprinting
12/04/2008CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
12/04/2008CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity
12/04/2008CA2687942A1 Therapeutic agent for cerebral infarction
12/04/2008CA2687381A1 Method of treating diabetes
12/04/2008CA2686560A1 Prophylactic or therapeutic agent for age-related macular degeneration
12/03/2008EP1997510A1 Non-neurotoxic plasminogen-activating factors for treating strokes
12/03/2008EP1997504A1 Novel antithrombotic agent
12/03/2008EP1997501A2 Extracts from Ajuga reptans cell lines, their preparation and use
12/03/2008EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/03/2008EP1997487A1 Product for use in the prevention and treatment of cardiovascular diseases, cancer and chronic inflammatory diseases
12/03/2008EP1997483A1 Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system
12/03/2008EP1996588A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors
12/03/2008EP1996582A2 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-ý2-methyl-4,5-(methylenedioxy) phenylacetyl¨thiophene-3-sulfonamide, sodium salt
12/03/2008EP1996580A2 Pyrrazole derivatives as sigma receptors antagonists
12/03/2008EP1996564A1 Dibenzyl amine compounds and derivatives
12/03/2008EP1996545A1 Soluble epoxide hydrolase inhibitors and methods of using same
12/03/2008EP1996542A2 Aliskiren nitrate salt
12/03/2008EP1996233A2 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
12/03/2008EP1996219A2 Treatment of ischemic disease using thrombopoietin
12/03/2008EP1996198A1 Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar
12/03/2008EP1996181A1 Cardioplegic solution
12/03/2008EP1996162A2 Methods and compositions for treatment of diastolic heart failure
12/03/2008EP1996161A2 Nanoparticulate carvedilol formulations
12/03/2008EP1804807B1 Coadministration of tigecycline and digoxin
12/03/2008EP1751153B1 Hetaryloxy-substituted phenylamino pyrimidines as rho kinase inhibitors
12/03/2008EP1663192B1 hERG1 CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS
12/03/2008EP1549615B1 Naphthamide derivatives and their use
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008EP1511499B1 Immunomodulatory compounds and methods of use thereof
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1470144B1 Oligonucleotides comprising alternating segments and uses thereof
12/03/2008EP1430031B1 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
12/03/2008EP1390045B1 The use of a compound with a negatively charged domain of phosphorous-containing radicals for the treatment of restenosis
12/03/2008EP1383787B1 Sapogenin derivatives, their synthesis and use
12/03/2008EP1377540B1 Inhibitors of integrin alpha-v-beta-6
12/03/2008EP1068202B1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
12/03/2008CN101316863A Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques
12/03/2008CN101316842A Acid addition salt of optically active dihydropyridine derivative
12/03/2008CN101316839A Acid addition salt of dihydropyridine derivative
12/03/2008CN101316827A Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316822A 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316821A Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316626A Methods for reducing blood pressure
12/03/2008CN101316596A Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid
12/03/2008CN101314769A Staphylokinase and expression vector thereof
12/03/2008CN101314763A Short bifidobacteria with functions of anti-gastrointestinal tract pathogen, oxidation resistance and blood pressure reduction
12/03/2008CN101314620A Singular polysaccharide of lactobacillus casei exocellular polysaccharide, preparation and application thereof
12/03/2008CN101314591A Novel pyrazoles highly-selective marijuana acceptor-1antagon and/or reversed activation agent
12/03/2008CN101314045A Sulphur butyl ether-beta-cyclodextrin clathrate compound of cinnarizine, formulated product and preparation method thereof
12/03/2008CN101314021A Chinese medicinal composition for dispelling wind and relieving paralysis
12/03/2008CN101314002A Medicament for treating blood supply insufficiency of brain